Is fluorine-18-fluorocholine PET/CT suitable for the detection of skeletal involvement of multiple myeloma?

Zuzana Meckova; Lukas Lambert; Ivan Spicka; Jozef Kubinyi; Andrea Burgetova

doi:10.1967/s002449910900

Is fluorine-18-fluorocholine PET/CT suitable for the detection of skeletal involvement of multiple myeloma?

Hell J Nucl Med. 2018 Sep-Dec;21(3):167-168. doi: 10.1967/s002449910900. Epub 2018 Nov 10.

Authors

Zuzana Meckova¹, Lukas Lambert, Ivan Spicka, Jozef Kubinyi, Andrea Burgetova

Affiliation

¹ Institute of Nuclear Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic. lambert.lukas@gmail.com.

PMID: 30411725
DOI: 10.1967/s002449910900

Abstract

Our limited experience suggests that fluorine-18-fluorocholine (¹⁸F-FCH) may perform better in the detection of skeletal involvement by multiple myeloma compared to fluorine-18-fluorodeoxyglucose (¹⁸F-FDG) and that standard uptake ratio (SUR) might be considered in the semi-quantitative comparison of tracer uptake.

MeSH terms

Choline / analogs & derivatives*
Feasibility Studies
Humans
Middle Aged
Multiple Myeloma / diagnostic imaging*
Multiple Myeloma / pathology
Muscle, Skeletal / diagnostic imaging*
Muscle, Skeletal / pathology
Positron Emission Tomography Computed Tomography*

Substances

fluorocholine
Choline